Arroliga Alejandro C, Shehab Nadine, McCarthy Kevin, Gonzales Jeffrey P
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Crit Care Med. 2004 Aug;32(8):1709-14. doi: 10.1097/01.ccm.0000134831.40466.39.
The primary objective was to evaluate the relationship between high-dose lorazepam and serum propylene glycol concentrations. Secondary objectives were a) to document the occurrence of propylene glycol accumulation associated with continuous high-dose lorazepam infusion; b) to assess the relationship between lorazepam dose, serum propylene glycol concentrations, and propylene glycol accumulation; and c) to assess the relationship between the osmol gap and serum propylene glycol concentrations.
Prospective, observational study.
Tertiary care, medical intensive care unit.
Nine critically ill adults receiving high-dose lorazepam (> or =10 mg/hr) infusion.
Cumulative lorazepam dose (mg/kg) and the rate of infusion (mg.kg(-1).hr(-1)) were monitored from initiation of lorazepam infusion until 24 hrs after discontinuation of the high-dose lorazepam infusion. Serum osmolarity was collected at 48 hrs into the high-dose lorazepam infusion and daily thereafter. Serum propylene glycol concentrations were drawn at 48 hrs into the high-dose lorazepam infusion, and the presence of propylene glycol accumulation, as evidenced by a high anion gap (> or =15 mmol/L) metabolic acidosis with elevated osmol gap (> or =10 mOsm/L), was assessed at that time.
The mean cumulative high-dose lorazepam received and mean high-dose lorazepam infusion rate were 8.1 mg/kg (range, 5.1-11.7) and 0.16 mg.kg(-1).hr (-1)(range, 0.11-0.22), respectively. A significant correlation between high-dose lorazepam infusion rate and serum propylene glycol concentrations was observed (r =.557, p =.021). Osmol gap was the strongest predictor of serum propylene glycol concentrations (r =.804, p =.001). Propylene glycol accumulation was observed in six of nine patients at 48 hrs. No significant correlation between duration of lorazepam infusion and serum propylene glycol concentrations was observed (p =.637).
Propylene glycol accumulation, as reflected by a hyperosmolar anion gap metabolic acidosis, was observed in critically ill adults receiving continuous high-dose lorazepam infusion for > or =48 hrs. Study findings suggest that in critically ill adults with normal renal function, serum propylene glycol concentrations may be predicted by the high-dose lorazepam infusion rate and osmol gap.
主要目的是评估大剂量劳拉西泮与血清丙二醇浓度之间的关系。次要目的是:a)记录与持续大剂量劳拉西泮输注相关的丙二醇蓄积情况;b)评估劳拉西泮剂量、血清丙二醇浓度与丙二醇蓄积之间的关系;c)评估渗透压间隙与血清丙二醇浓度之间的关系。
前瞻性观察性研究。
三级医疗中心的医学重症监护病房。
9名接受大剂量劳拉西泮(≥10mg/小时)输注的重症成年患者。
从劳拉西泮输注开始至大剂量劳拉西泮输注停止后24小时,监测劳拉西泮累积剂量(mg/kg)和输注速率(mg·kg⁻¹·小时⁻¹)。在大剂量劳拉西泮输注48小时时及之后每天采集血清渗透压。在大剂量劳拉西泮输注48小时时测定血清丙二醇浓度,并在此时评估是否存在丙二醇蓄积,表现为高阴离子间隙(≥15mmol/L)代谢性酸中毒伴渗透压间隙升高(≥10mOsm/L)。
接受的平均累积大剂量劳拉西泮和平均大剂量劳拉西泮输注速率分别为8.1mg/kg(范围5.1 - 11.7)和0.16mg·kg⁻¹·小时⁻¹(范围0.11 - 0.22)。观察到大剂量劳拉西泮输注速率与血清丙二醇浓度之间存在显著相关性(r = 0.557,p = 0.021)。渗透压间隙是血清丙二醇浓度的最强预测指标(r = 0.804,p = 0.001)。9名患者中有6名在48小时时出现丙二醇蓄积。未观察到劳拉西泮输注持续时间与血清丙二醇浓度之间存在显著相关性(p = 0.637)。
在接受持续大剂量劳拉西泮输注≥48小时的重症成年患者中,观察到高渗性阴离子间隙代谢性酸中毒所反映的丙二醇蓄积。研究结果表明,在肾功能正常的重症成年患者中,血清丙二醇浓度可通过大剂量劳拉西泮输注速率和渗透压间隙来预测。